Ocugen, Inc.
Key Metrics
- Previous Close
- $0.76
- 52-Week Range
- $0.69 – $2.73
- Market Cap
- $250.82M
- P/E (TTM)
- —
- EPS (TTM)
- -0.20
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- —
- Return on Equity
- —
- Return on Assets
- -52.09%
- Gross Margin
- 0.00%
- Operating Margin
- -1444.14%
- Profit Margin
- 0.00%
- Current Ratio
- 0.77
- Debt/Equity
- —
- Total Debt
- $88.56M
- Free Cash Flow
- $-21.49M
- Revenue Growth
- 11.40%
- Earnings Growth
- —
- Enterprise Value
- $255.12M
Market Snapshot
About
Ocugen, Inc. is a biotechnology company developing gene therapies and cell therapies to cure blindness and treat eye diseases including inherited retinal diseases.